HCAT Health Catalyst Inc

Price (delayed)

$7.39

Market cap

$425.3M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.24

Enterprise value

$579.62M

Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its customers leverage ...

Highlights
HCAT's EPS is up by 21% year-on-year and by 17% since the previous quarter
The net income has grown by 18% YoY and by 16% from the previous quarter
Health Catalyst's quick ratio has decreased by 6% YoY but it has increased by 2.2% from the previous quarter
The company's equity fell by 10% YoY
Health Catalyst's gross margin has decreased by 7% YoY

Key stats

What are the main financial stats of HCAT
Market
Shares outstanding
57.55M
Market cap
$425.3M
Enterprise value
$579.62M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.1
Price to sales (P/S)
1.45
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2
Earnings
Revenue
$290.02M
EBIT
-$130.86M
EBITDA
-$84.23M
Free cash flow
-$42.52M
Per share
EPS
-$2.24
Free cash flow per share
-$0.75
Book value per share
$6.71
Revenue per share
$5.11
TBVPS
$8.02
Balance sheet
Total assets
$712.92M
Total liabilities
$330.53M
Debt
$249.29M
Equity
$382.39M
Working capital
$324.2M
Liquidity
Debt to equity
0.65
Current ratio
4.85
Quick ratio
4.67
Net debt/EBITDA
-1.83
Margins
EBITDA margin
-29%
Gross margin
45.6%
Net margin
-42.6%
Operating margin
-45.1%
Efficiency
Return on assets
-16.8%
Return on equity
-30.9%
Return on invested capital
-25.6%
Return on capital employed
-20.8%
Return on sales
-45.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

HCAT stock price

How has the Health Catalyst stock price performed over time
Intraday
-0.34%
1 week
-4.27%
1 month
7.73%
1 year
-23.26%
YTD
-30.48%
QTD
-26.98%

Financial performance

How have Health Catalyst's revenue and profit performed over time
Revenue
$290.02M
Gross profit
$132.38M
Operating income
-$130.86M
Net income
-$123.62M
Gross margin
45.6%
Net margin
-42.6%
The company's net margin rose by 23% YoY and by 18% QoQ
The net income has grown by 18% YoY and by 16% from the previous quarter
The operating margin rose by 17% YoY and by 16% QoQ
The operating income is up by 14% since the previous quarter and by 12% year-on-year

Growth

What is Health Catalyst's growth rate over time

Valuation

What is Health Catalyst stock price valuation
P/E
N/A
P/B
1.1
P/S
1.45
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2
HCAT's EPS is up by 21% year-on-year and by 17% since the previous quarter
HCAT's price to book (P/B) is 69% lower than its 5-year quarterly average of 3.6 and 31% lower than its last 4 quarters average of 1.6
The company's equity fell by 10% YoY
The stock's price to sales (P/S) is 75% less than its 5-year quarterly average of 5.8 and 34% less than its last 4 quarters average of 2.2
The company's revenue rose by 7% YoY

Efficiency

How efficient is Health Catalyst business performance
HCAT's ROS is up by 17% year-on-year and by 16% since the previous quarter
Health Catalyst's return on assets has increased by 15% QoQ and by 14% YoY
HCAT's return on equity is up by 14% since the previous quarter and by 8% year-on-year
The ROIC has grown by 14% from the previous quarter and by 11% YoY

Dividends

What is HCAT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for HCAT.

Financial health

How did Health Catalyst financials performed over time
HCAT's total assets is 116% greater than its total liabilities
The current ratio has contracted by 6% YoY but it has grown by 2.3% from the previous quarter
Health Catalyst's quick ratio has decreased by 6% YoY but it has increased by 2.2% from the previous quarter
The company's debt is 35% lower than its equity
The debt to equity is up by 12% year-on-year
The company's equity fell by 10% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.